|
|
||||||||||
1 Clinical Pharmacist, Drug Information, Blue Shield of California, San
Francisco, CA
2 Clinical Coordinator, Pharmacy Services, Veterans Affairs Palo Alto Health
Care System, Palo Alto, CA
3 Associate Professor of Surgery (Emergency Medicine), Stanford University
Medical Center, Palo Alto
Reprints: Dr. Hasson, Pharmacy Services, VA Palo Alto Health Care System, 3801 Miranda Ave. (119), Palo Alto, CA 94304-1290, fax 650/852-3444, noelle.hasson{at}med.va.gov
BACKGROUND: Given that adverse drug events result in extensive costs and healthcare resource utilization, the goal is to better understand drug-related emergency department (ED) visits so that programs can be implemented to improve the quality of health care.
OBJECTIVE: To (1) determine the incidence of drug-related ED visits at a large, tertiary care, Veterans Affairs hospital; (2) identify causes of these drug-related ED visits; (3) determine patient outcomes, healthcare resource utilization, and costs associated with these visits; and (4) determine the proportion of adverse drug reaction (ADR)-related ED visits that were spontaneously reported to the hospital's ADR reporting program.
METHODS: We conducted a retrospective electronic chart review of all patients who visited the ED during the second week of each month in 2003. Causes for drug-related visits were identified. ADRs in this study included side effects, drug allergies, and drug-drug interactions (DDIs) and were assessed using the Naranjo probability scale.
RESULTS: A total of 2169 patients were included in the study. Drug-related visits accounted for 12.6% of all ED visits. The main causes of drug-related visits were ADRs and nonadherence, which accounted for 33% and 19% of drug-related visits, respectively. Only 11% of these ADRs were spontaneously reported to the hospital's ADR reporting program. Thirty-five percent of drug-related visits led to hospitalizations, which resulted in an average length of stay of 9.3 days. The institution's total cost of drug-related visits was approximately $1.5 million over 12 weeks.
CONCLUSIONS: Many ED visits are drug related and often result in hospitalization and increased healthcare resource utilization. Only a minimal number of the ADRs resulting in ED visits are spontaneously reported to hospital ADR reporting programs.
Key Words: adverse drug reactions, costs, emergency department, outcomes
Published Online, November 15, 2005. www.theannals.com, DOI 10.1345/aph.1E541
This article has been cited by other articles:
![]() |
T. L. Hayes, N. Larimer, A. Adami, and J. A. Kaye Medication Adherence in Healthy Elders: Small Cognitive Changes Make a Big Difference J Aging Health, June 1, 2009; 21(4): 567 - 580. [Abstract] [PDF] |
||||
![]() |
D. J. Cobaugh, E. Angner, C. I. Kiefe, M. N. Ray, C. L. LaCivita, N. W. Weissman, K. G. Saag, and J. J. Allison Effect of racial differences on ability to afford prescription medications Am. J. Health Syst. Pharm., November 15, 2008; 65(22): 2137 - 2143. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Manias, K. Claydon-Platt, G. J McColl, T. K Bucknall, and C. A Brand Managing Complex Medication Regimens: Perspectives of Consumers with Osteoarthritis and Healthcare Professionals Ann. Pharmacother., May 1, 2007; 41(5): 764 - 771. [Abstract] [Full Text] [PDF] |
||||